Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 30, 2024
December 30, 2024
12be365f-ede2-4671-b6b7-8da74c7c3635
Related Documents
Investigator Responsibilities – Safety Reporting for Investigational Drugs and Devices: Draft Guidance for Industry
Guidance DocumentSeptember 29, 2021Center for Drug Evaluation and Research
Use of Data Monitoring Committees in Clinical Trials
Guidance DocumentFebruary 13, 2024Center for Drug Evaluation and Research
Addressing Misinformation About Medical Devices and Prescription Drugs: Questions and Answers
Guidance DocumentJuly 8, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox